MIMEDX GROUP INC
For the period ended Dec 31, 2023. Filed Feb 28, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 28, 2024
MDXG$3.37+1.5%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Financial Statements and Supplementary Data
| Index to Financial Statements | |
|---|---|
| Report of Deloitte & Touche LLP, Independent Registered Public Accounting Firm (PCAOB ID: 34) | F- 2 |
| Consolidated Balance Sheets – As of December 31, 2023 and 2022 | F- 4 |
| Consolidated Statements of Operations – For the years ended December 31, 2023, 2022 and 2021 | F- 5 |
| Consolidated Statements of Stockholders’ Equity (Deficit) – For the years ended December 31, 2023, 2022 and 2021 | F- 6 |
| Consolidated Statements of Cash Flows – For the years ended December 31, 2023, 2022 and 2021 | F- 7 |
| Notes to Consolidated Financial Statements | F- 8 |
F- 1
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.